GERON CORP GERN (NASDAQ) $ 2.60 Change: +0.37 +14.23% | Volume: 1,734,650
Sponsored by Click here!

GERON CORP - Fundamental Profile

Company Information

Ticker Symbol: GERN
Exchange: NASD
Contact Info: 230 Constitution Drive Menlo Park CA 94025 650 473-7700
CEO/President: Thomas B. Okarma Ph.D.
Industry: Medical - Biomedical / Standard Industry Code: 2834
Description: Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.

Share Information

Shares Outstanding: 77,900 (000) Market Value: 175,380 ($000)
Percentage of Inst.Shareholders: 23.39% Number of Inst.Shareholders: 7.34%
Last Quarter Sales: 0.20 ($Mil.) Last Quarter Net Income: -13.56 ($Mil.)
Last Quarter EPS: -0.17 P/E Ratio: 0
Most Recent Earnings: -0.18 on 04/29/08 Earnings Per Share: -0.74
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN -10.70 50.26
GILEAD SCIENCES -19.00 40.04
GENENTECH INC +0.80 78.75
CELGENE CP -22.80 56.55
BIOGEN IDEC INC -30.50 44.76